Isabela Girleanu

@IsabelaGirleanu

RGN/PhD scholar at Trinity College Dublin/Research interests (not limited to) cancer care and survivorship/All views are my own!

Dublin City, Ireland Joined December 2018

203 Following 58 Followers 15 Posts

Latest posts 5

Isabela Girleanu @IsabelaGirleanu Oct 6

Researchers at @TCD_SNM and @TCPHI_TCD are conducting a study to understand the experiences of adults who have received CAR-T therapy for a blood cancer diagnosis, from treatment through survivorship.

Who should take part:
Adults who have received, or are currently receiving, CAR-T therapy for lymphoma, leukaemia, or myeloma to share their experiences and perspectives on life during and after treatment. Your insights could help improve care and support for people receiving CAR-T therapy.

What is involved:
◽ An interview at a time and location that suits you, either in person, online, or by phone.
◽There is a Participant Information Leaflet for further information that can be accessed at eu.surveymonkey.com/r/7SCVVZM. This link can also be used to register your interest.
◽If you are interested or have any questions, please contact us at: email: girleani@tcd.ie / phone: 087 335 1883. If you would like a paper copy of the Participant Information Leaflet please let us know.

Thank you for considering taking part in our study.

@CancerInstIRE
@IrishCancerSoc
@IANOCancerNurse
@TheEBMT_Nurses
@vanessaboland
@abrady4

Isabela Girleanu @IsabelaGirleanu Apr 24

I had the pleasure of receiving this year Trinity Careers Service Skills Award.

Truly inspiring journey which provided a fantastic opportunity to enhance my professional experience and skills. Thank you to @TCDCareers for organising such an engaging programme.

Isabela Girleanu @IsabelaGirleanu Apr 22

This Saturday I had the pleasure of attending the @IANOCancerNurse Conference to present my poster titled “The unmet needs of patients receiving CAR-T therapy: a scoping review” and I am delighted to have been awarded the “Best up and Coming” prize. #IANO @TCD_SNM

Isabela Girleanu @IsabelaGirleanu Feb 14

Last day of the EBMT-EHA 8th CAR-T Cell Meeting. Thankful to have been awarded one of the travel grants which made it possible to present my work during the poster session and engage in meaningful discussions with colleagues from across the field @TheEBMT_Nurses @TheEBMT. #CART26

Isabela Girleanu @IsabelaGirleanu Feb 12

My scoping review titled "Mapping the experiences of adult cancer patients receiving chimeric antigen receptor T-cell (CAR-T) therapy: A scoping review protocol” can now be accesed on ⁦⁦@ResearchGate⁩: researchgate.net/publication/39…

www.researchgate.net (PDF) Mapping the experiences of adult cancer patients receiving chimeric antigen receptor T-cell... PDF | Introduction Chimeric antigen receptor T-cell (CAR T) therapy is an advancement in cancer treatments, particularly for patients with... | Find, read and cite all the research you need on...